Is OPWEF or JNJ a better dividend investment in 2026?

OPWEF currently yields 2820.87% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: OPWEF offers higher current income.

What is the dividend yield difference between OPWEF and JNJ?

OPWEF has a forward dividend yield of 2820.87% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 2817.51 percentage points.

Home › Compare › OPWEF vs JNJ

OPWEF vs JNJ: Dividend Comparison 2026

OPWEF yields 2820.87% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 OPWEF wins by $253050367702.97M in total portfolio value

INVESTMENT

TIME HORIZON10 years

OPWEF

● Live price

2820.87%

Share price

$0.07

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$253050367702.99M

Annual income

$236,554,142,597,846,560.00

Full OPWEF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — OPWEF vs JNJ

📍 OPWEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	OPWEF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, OPWEF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

OPWEF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OPWEF

Annual income on $10K today (after 15% tax)

$239,774.33/yr

After 10yr DRIP, annual income (after tax)

$201,071,021,208,169,570.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, OPWEF beats the other by $201,071,021,208,168,860.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OPWEF + JNJ for your $10,000?

OPWEF: 50%JNJ: 50%

100% JNJ50/50100% OPWEF

Portfolio after 10yr

$126525183851.50M

Annual income

$118,277,071,298,923,700.00/yr

Blended yield

93.48%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OPWEF

No analyst data

Altman Z

-10.4

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OPWEF buys

JNJ buys

No recent congressional trades found for OPWEF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricOPWEFJNJ

Forward yield	2820.87% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$253050367702.99M ✓	$20.0K
Annual income after 10y	$236,554,142,597,846,560.00 ✓	$827.78
Total dividends collected	$251905977930.38M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: OPWEF vs JNJ ($10,000, DRIP)

Year	OPWEF Portfolio	OPWEF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$292,787	$282,087.45	$10,676	$355.77	+$282.1K → OPWEF
2	$8,032,130	$7,718,847.06	$11,407	$389.39	+$8.02M → OPWEF
3	$206,494,889	$197,900,510.14	$12,198	$426.53	+$206.48M → OPWEF
4	$4,975,853,321	$4,754,903,789.83	$13,056	$467.62	+$4975.84M → OPWEF
5	$112,406,100,271	$107,081,937,217.52	$13,987	$513.12	+$112406.09M → OPWEF
6	$2,381,036,050,077	$2,260,761,522,786.75	$14,998	$563.56	+$2381036.04M → OPWEF
7	$47,303,275,755,396	$44,755,567,181,814.38	$16,098	$619.52	+$47303275.74M → OPWEF
8	$881,590,605,677,983	$830,976,100,619,709.10	$17,295	$681.69	+$881590605.66M → OPWEF
9	$15,417,032,808,543,500	$14,473,730,860,468,058.00	$18,599	$750.82	+$15417032808.52M → OPWEF
10	$253,050,367,702,988,100	$236,554,142,597,846,560.00	$20,022	$827.78	+$253050367702.97M → OPWEF

OPWEF vs JNJ: Complete Analysis 2026

OPWEF — Stock

Opawica Explorations Inc., a junior resource company, engages in the acquisition, exploration, and evaluation of mineral properties in Canada. It explores for gold and base metal deposits. The company holds 100% interests in the Arrowhead property that consists of 19 mineral claims covering an area of 400.76 hectares located in the Joannes Township, Quebec; and the Bazooka property, which comprises 41 mineral claims covering an area of 1320.92 hectares located in the Beauchastel Township, Quebec. It also holds 100% interests in the Richard Copper property that includes 4 mineral claims located to Rouyn Noranda, Quebec, as well as in the Lil d'Espoir Lake property, which comprises 176 mineral claims covering an area of approximately 44 square kilometers; and the Chapel Island property consisting of 173 mineral claims covering an area of approximately 43.25 square kilometers located in the Exploits Subzone of Central Newfoundland and Labrador. In addition, the company holds 70% interests in the Density, Eclipse, and Mass properties that includes 906 mineral claims located in Newfoundland and Labrador. It also holds an option to acquire a 100% interest in Enterprise property, which comprises 308 mineral claims located in the Exploits Subzone of Central Newfoundland and Labrador. Opawica Explorations Inc. was incorporated in 1975 and is based in Vancouver, Canada.

Full OPWEF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this OPWEF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OPWEF vs SCHD OPWEF vs JEPI OPWEF vs O OPWEF vs KO OPWEF vs MAIN OPWEF vs ABBV OPWEF vs MRK OPWEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.